| Entry |
|
|---|
| Name |
Taurine;
2-Aminoethanesulfonic acid;
Aminoethylsulfonic acid
|
|---|
| Formula |
C2H7NO3S
|
|---|
| Exact mass |
125.0147
|
|---|
| Mol weight |
125.15
|
|---|
| Structure |
|
|---|
| Remark |
|
|---|
| Reaction |
|
|---|
| Pathway |
| map00430 | Taurine and hypotaurine metabolism |
| map04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Enzyme |
|
|---|
| Brite |
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
11 Agents affecting central nervous system
119 Miscellaneous
1190 Miscellaneous
D00047 Taurine (JP18/USP/INN); Aminoethylsulfonic acid (JAN)
2 Agents affecting individual organs
21 Cardiovascular agents
211 Cardiotonics
2119 Others
D00047 Taurine (JP18/USP/INN); Aminoethylsulfonic acid (JAN)
3 Agents affecting metabolism
39 Other agents affecting metabolism
391 Liver disease agents
3919 Others
D00047 Taurine (JP18/USP/INN); Aminoethylsulfonic acid (JAN)
Classification of Japanese OTC drugs [BR:br08313]
Agents for ophthalmologic use
62 General eye drops
D00047 Taurine (JP18/USP/INN)
Risk category of Japanese OTC drugs [BR:br08312]
Third-class OTC drugs
Inorganic and organic chemicals
Aminoethylsulfonic acid; Taurine
D00047 Taurine (JP18/USP/INN)
Animal drugs in Japan [BR:br08331]
96 Agents affecting metabolism
967 Agents for liver disease and antidotes
9674 Taurine and preparations
C00245 Aminoethylsulfonic acid
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00047 Taurine
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 7
1 C1b C 26.3067 -17.5328
2 S4a S 27.5163 -16.8350
3 C1b C 25.0914 -16.8350
4 O1d O 28.7256 -17.5328
5 N1a N 23.8820 -17.5328
6 O1d O 28.6445 -15.9863
7 O1d O 26.3056 -16.1360
BOND 6
1 1 2 1
2 1 3 1
3 2 4 1
4 3 5 1
5 2 6 2
6 2 7 2
|
|---|
